Report Detail

Other Global Inherited Cancer Genome Testing Market Growth (Status and Outlook) 2022-2028

  • RnM4494795
  • |
  • 04 November, 2022
  • |
  • Global
  • |
  • 85 Pages
  • |
  • LPI(LP Information)
  • |
  • Other

According to this study, the global Inherited Cancer Genome Testing market size will reach US$ million by 2028.

This report presents a comprehensive overview, market shares, and growth opportunities of Inherited Cancer Genome Testing market by product type, application, key players and key regions and countries.

Segmentation by product type:
Breast Cancer
Lung Cancer
Blood Cancer
Liver Cancer
Stomach Cancer
Others

Segmentation by Application:
General Hospitals
Specialty Clinics

This report also splits the market by region:
United States
China
Europe
Other regions:
Japan
South Korea
Southeast Asia
Rest of world

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:
23andMe
Agilent Technologies
Bio-Rad Laboratories
Centogene
Color Genomics
Gene By Gene
Illumina
LabCorp
Myriad Genetics
Positive Bioscience
Quest Diagnostics
Thermo Fisher Scientific


1 Scope of the Report

  • 1.1 Market Introduction
  • 1.2 Years Considered
  • 1.3 Research Objectives
  • 1.4 Market Research Methodology
  • 1.5 Research Process and Data Source
  • 1.6 Economic Indicators
  • 1.7 Currency Considered

2 Executive Summary

  • 2.1 World Market Overview
    • 2.1.1 Global Inherited Cancer Genome Testing Market Size 2022-2028
    • 2.1.2 Inherited Cancer Genome Testing Market Size CAGR by Region
  • 2.2 Inherited Cancer Genome Testing Segment by Type
    • 2.2.1 Breast Cancer
    • 2.2.2 Lung Cancer
    • 2.2.3 Blood Cancer
    • 2.2.4 Liver Cancer
    • 2.2.5 Stomach Cancer
    • 2.2.6 Others
  • 2.3 Inherited Cancer Genome Testing Market Size by Type
    • 2.3.1 Global Inherited Cancer Genome Testing Market Size Market Share by Type (2022-2028)
    • 2.3.2 Global Inherited Cancer Genome Testing Market Size Growth Rate by Type (2022-2028)
  • 2.4 Inherited Cancer Genome Testing Segment by Application
    • 2.4.1 General Hospitals
    • 2.4.2 Specialty Clinics
  • 2.5 Inherited Cancer Genome Testing Market Size by Application
    • 2.5.1 Global Inherited Cancer Genome Testing Market Size Market Share by Application (2022-2028)
    • 2.5.2 Global Inherited Cancer Genome Testing Market Size Growth Rate by Application (2022-2028)

3 Inherited Cancer Genome Testing Key Players

  • 3.1 Date of Key Players Enter into Inherited Cancer Genome Testing
  • 3.2 Key Players Inherited Cancer Genome Testing Product Offered
  • 3.3 Key Players Inherited Cancer Genome Testing Funding/Investment Analysis
  • 3.4 Funding/Investment
    • 3.4.1 Funding/Investment by Regions
    • 3.4.2 Funding/Investment by End-Industry
  • 3.5 Key Players Inherited Cancer Genome Testing Valuation & Market Capitalization
  • 3.6 Key Players Mergers & Acquisitions, Expansion Plans
  • 3.7 Market Ranking
  • 3.8 New Product/Technology Launches
  • 3.9 Partnerships, Agreements, and Collaborations
  • 3.10 Mergers and Acquisitions

4 Inherited Cancer Genome Testing by Regions

  • 4.1 Inherited Cancer Genome Testing Market Size by Regions (2022-2028)
  • 4.2 United States Inherited Cancer Genome Testing Market Size Growth (2022-2028)
  • 4.3 China Inherited Cancer Genome Testing Market Size Growth (2022-2028)
  • 4.4 Europe Inherited Cancer Genome Testing Market Size Growth (2022-2028)
  • 4.5 Rest of World Inherited Cancer Genome Testing Market Size Growth (2022-2028)

5 United States

  • 5.1 United States Inherited Cancer Genome Testing Market Size by Type (2022-2028)
  • 5.2 United States Inherited Cancer Genome Testing Market Size by Application (2022-2028)

6 China

  • 6.1 China Inherited Cancer Genome Testing Market Size by Type (2022-2028)
  • 6.2 China Inherited Cancer Genome Testing Market Size by Application (2022-2028)

7 Europe

  • 7.1 Europe Inherited Cancer Genome Testing Market Size by Type (2022-2028)
  • 7.2 Europe Inherited Cancer Genome Testing Market Size by Application (2022-2028)

8 Rest of World

  • 8.1 Rest of World Inherited Cancer Genome Testing Market Size by Type (2022-2028)
  • 8.2 Rest of World Inherited Cancer Genome Testing Market Size by Application (2022-2028)
  • 8.3 Japan
  • 8.4 South Korea
  • 8.5 Southeast Asia

9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers & Growth Opportunities
  • 9.2 Market Challenges & Risks
  • 9.3 Industry Trends

10 Key Investors in Inherited Cancer Genome Testing

  • 10.1 Company A
    • 10.1.1 Company A Company Details
    • 10.1.2 Company Description
    • 10.1.3 Companies Invested by Company A
    • 10.1.4 Company A Key Development and Market Layout
  • 10.2 Company B
    • 10.2.1 Company B Company Details
    • 10.2.2 Company Description
    • 10.2.3 Companies Invested by Company B
    • 10.2.4 Company B Key Development and Market Layout
  • 10.3 Company C
    • 10.3.1 Company C Company Details
    • 10.3.2 Company Description
    • 10.3.3 Companies Invested by Company C
    • 10.3.4 Company C Key Development and Market Layout
  • 10.4 Company D
  • 10.5 ……

11 Key Players Analysis

  • 11.1 23andMe
    • 11.1.1 23andMe Company Details
    • 11.1.2 23andMe Inherited Cancer Genome Testing Product Offered
    • 11.1.3 23andMe Inherited Cancer Genome Testing Market Size (2022 VS 2027)
    • 11.1.4 23andMe Main Business Overview
    • 11.1.5 23andMe News
  • 11.2 Agilent Technologies
    • 11.2.1 Agilent Technologies Company Details
    • 11.2.2 Agilent Technologies Inherited Cancer Genome Testing Product Offered
    • 11.2.3 Agilent Technologies Inherited Cancer Genome Testing Market Size (2022 VS 2027)
    • 11.2.4 Agilent Technologies Main Business Overview
    • 11.2.5 Agilent Technologies News
  • 11.3 Bio-Rad Laboratories
    • 11.3.1 Bio-Rad Laboratories Company Details
    • 11.3.2 Bio-Rad Laboratories Inherited Cancer Genome Testing Product Offered
    • 11.3.3 Bio-Rad Laboratories Inherited Cancer Genome Testing Market Size (2022 VS 2027)
    • 11.3.4 Bio-Rad Laboratories Main Business Overview
    • 11.3.5 Bio-Rad Laboratories News
  • 11.4 Centogene
    • 11.4.1 Centogene Company Details
    • 11.4.2 Centogene Inherited Cancer Genome Testing Product Offered
    • 11.4.3 Centogene Inherited Cancer Genome Testing Market Size (2022 VS 2027)
    • 11.4.4 Centogene Main Business Overview
    • 11.4.5 Centogene News
  • 11.5 Color Genomics
    • 11.5.1 Color Genomics Company Details
    • 11.5.2 Color Genomics Inherited Cancer Genome Testing Product Offered
    • 11.5.3 Color Genomics Inherited Cancer Genome Testing Market Size (2022 VS 2027)
    • 11.5.4 Color Genomics Main Business Overview
    • 11.5.5 Color Genomics News
  • 11.6 Gene By Gene
    • 11.6.1 Gene By Gene Company Details
    • 11.6.2 Gene By Gene Inherited Cancer Genome Testing Product Offered
    • 11.6.3 Gene By Gene Inherited Cancer Genome Testing Market Size (2022 VS 2027)
    • 11.6.4 Gene By Gene Main Business Overview
    • 11.6.5 Gene By Gene News
  • 11.7 Illumina
    • 11.7.1 Illumina Company Details
    • 11.7.2 Illumina Inherited Cancer Genome Testing Product Offered
    • 11.7.3 Illumina Inherited Cancer Genome Testing Market Size (2022 VS 2027)
    • 11.7.4 Illumina Main Business Overview
    • 11.7.5 Illumina News
  • 11.8 LabCorp
    • 11.8.1 LabCorp Company Details
    • 11.8.2 LabCorp Inherited Cancer Genome Testing Product Offered
    • 11.8.3 LabCorp Inherited Cancer Genome Testing Market Size (2022 VS 2027)
    • 11.8.4 LabCorp Main Business Overview
    • 11.8.5 LabCorp News
  • 11.9 Myriad Genetics
    • 11.9.1 Myriad Genetics Company Details
    • 11.9.2 Myriad Genetics Inherited Cancer Genome Testing Product Offered
    • 11.9.3 Myriad Genetics Inherited Cancer Genome Testing Market Size (2022 VS 2027)
    • 11.9.4 Myriad Genetics Main Business Overview
    • 11.9.5 Myriad Genetics News
  • 11.10 Positive Bioscience
    • 11.10.1 Positive Bioscience Company Details
    • 11.10.2 Positive Bioscience Inherited Cancer Genome Testing Product Offered
    • 11.10.3 Positive Bioscience Inherited Cancer Genome Testing Market Size (2022 VS 2027)
    • 11.10.4 Positive Bioscience Main Business Overview
    • 11.10.5 Positive Bioscience News
  • 11.11 Quest Diagnostics
  • 11.12 Thermo Fisher Scientific

12 Research Findings and Conclusion

Summary:
Get latest Market Research Reports on Inherited Cancer Genome Testing. Industry analysis & Market Report on Inherited Cancer Genome Testing is a syndicated market report, published as Global Inherited Cancer Genome Testing Market Growth (Status and Outlook) 2022-2028. It is complete Research Study and Industry Analysis of Inherited Cancer Genome Testing market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

Last updated on

REPORT YOU MIGHT BE INTERESTED

Purchase this Report

$3,660.00
$7,320.00
2,986.56
5,973.12
3,477.00
6,954.00
492,709.20
985,418.40
297,850.80
595,701.60
Credit card Logo

Related Reports


Reason to Buy

Request for Sample of this report